SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Arovella Therapeutics appoints Nicole van der Weerden acting CEO

Arovella Therapeutics appointed Dr Nicole van der Weerden as acting CEO, effective today.

Related stories